These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 20626352)
1. Pharmacogenetics and human genetic polymorphisms. Daly AK Biochem J; 2010 Aug; 429(3):435-49. PubMed ID: 20626352 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacogenomics: the quest for individualized therapy]. López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF; Liu JP; Chowbay B Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms affecting drug metabolism: recent advances and clinical aspects. Daly AK Adv Pharmacol; 2012; 63():137-67. PubMed ID: 22776641 [TBL] [Abstract][Full Text] [Related]
6. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]
8. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Reynolds GP; Templeman LA; Zhang ZJ Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics/genomics and personalized medicine. Sadée W; Dai Z Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Johnson AD; Wang D; Sadee W Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120 [TBL] [Abstract][Full Text] [Related]
12. Evolution of pharmacogenomics. Somogy A Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663 [TBL] [Abstract][Full Text] [Related]
13. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness]. Ozawa S Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension. Mialet-Perez J; Liggett SB Arch Mal Coeur Vaiss; 2006 Jun; 99(6):616-20. PubMed ID: 16878723 [TBL] [Abstract][Full Text] [Related]
15. Overview of pharmacogenetics in anticoagulation therapy. Hill CE; Duncan A Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059 [TBL] [Abstract][Full Text] [Related]
17. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Lynch T; Price A Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140 [TBL] [Abstract][Full Text] [Related]
18. [State of the art of pharmacogenetic diagnostics in drug therapy]. Kirchheiner J; Seeringer A; Brockmöller J Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776 [TBL] [Abstract][Full Text] [Related]